These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 35108605)
21. High use of short-acting β Janson C; Wiklund F; Telg G; Stratelis G; Sandelowsky H ERJ Open Res; 2023 May; 9(3):. PubMed ID: 37342089 [TBL] [Abstract][Full Text] [Related]
22. The Association Between Short-Acting β Price D; Jenkins C; Hancock K; Vella R; Heraud F; Le Cheng P; Murray R; Beekman M; Bosnic-Anticevich S; Botini F; Carter V; Catanzariti A; Doan J; Fletton K; Kichkin A; Le T; Le Lievre C; Lau CM; Novic D; Pakos J; Ranasinghe K; Roussos A; Samuel-King J; Sharma A; Stewart D; Willet B; Bateman E; Adv Ther; 2024 Mar; 41(3):1262-1283. PubMed ID: 38310584 [TBL] [Abstract][Full Text] [Related]
23. SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada). Noorduyn SG; Qian C; Johnston KM; Soliman M; Talukdar M; Walker BL; Hernandez P; Penz E ERJ Open Res; 2022 Jul; 8(3):. PubMed ID: 36171990 [TBL] [Abstract][Full Text] [Related]
24. It is time to change the way we manage mild asthma: an update in GINA 2019. Muneswarao J; Hassali MA; Ibrahim B; Saini B; Ali IAH; Verma AK Respir Res; 2019 Aug; 20(1):183. PubMed ID: 31412856 [TBL] [Abstract][Full Text] [Related]
25. SABA Overuse in Russia - Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study. Avdeev S; Voznesenskiy N; Boldina M; Ignatova G; Kostina N; Kulbaisov A; Leshchenko I; Beekman MJHI J Asthma Allergy; 2022; 15():371-379. PubMed ID: 35368426 [TBL] [Abstract][Full Text] [Related]
34. The impact of inappropriate use of short acting beta agonists in asthma. FitzGerald JM; Tavakoli H; Lynd LD; Al Efraij K; Sadatsafavi M Respir Med; 2017 Oct; 131():135-140. PubMed ID: 28947020 [TBL] [Abstract][Full Text] [Related]
35. Pharmacist-managed short-acting beta agonist refill service in a general pediatric clinic. Gildon BL; John B; Condren M; Keast S; Maglunog R; Johnson JL; Robertson C J Am Pharm Assoc (2003); 2018; 58(3):296-302. PubMed ID: 29402662 [TBL] [Abstract][Full Text] [Related]
36. Effective Asthma Management: Is It Time to Let the AIR out of SABA? Kaplan A; Mitchell PD; Cave AJ; Gagnon R; Foran V; Ellis AK J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32230875 [TBL] [Abstract][Full Text] [Related]
37. Clarifying SABA overuse: Translating Canadian Thoracic Society guidelines into clinical practice. Ellis AK; Foran V; Kaplan A; Mitchell PD Allergy Asthma Clin Immunol; 2022 Jun; 18(1):48. PubMed ID: 35690850 [TBL] [Abstract][Full Text] [Related]
38. Over-prescription of short-acting β Alzaabi A; Al Busaidi N; Pradhan R; Shandy F; Ibrahim N; Ashtar M; Khudadah K; Hegazy K; Samir M; Negm M; Farouk H; Al Khalidi A; Beekman M Asthma Res Pract; 2022 Jul; 8(1):3. PubMed ID: 35799290 [TBL] [Abstract][Full Text] [Related]
39. Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability. Fan VS; Gylys-Colwell I; Locke E; Sumino K; Nguyen HQ; Thomas RM; Magzamen S Respir Med; 2016 Jul; 116():100-6. PubMed ID: 27296828 [TBL] [Abstract][Full Text] [Related]
40. Position statement: asthma in Latin America. IS short-acting beta-2 agonist helping or compromising asthma management? Nannini LJ; Luhning S; Rojas RA; Antunez JM; Miguel Reyes JL; Cano Salas C; Stelmach R J Asthma; 2021 Aug; 58(8):991-994. PubMed ID: 32482150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]